Cargando…
Proresolution Lipid Mediators in Multiple Sclerosis — Differential, Disease Severity-Dependent Synthesis — A Clinical Pilot Trial
BACKGROUND: The severity and longevity of inflammation is controlled by endogenous counter-regulatory signals. Among them are long-chain polyunsaturated fatty acid (PUFA)-derived lipid mediators, which promote the resolution of inflammation, an active process for returning to tissue homeostasis. OBJ...
Autores principales: | Prüss, Harald, Rosche, Berit, Sullivan, Aaron B., Brommer, Benedikt, Wengert, Oliver, Gronert, Karsten, Schwab, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3568070/ https://www.ncbi.nlm.nih.gov/pubmed/23409068 http://dx.doi.org/10.1371/journal.pone.0055859 |
Ejemplares similares
-
Proresolution Therapy for the Treatment of Delayed Healing of Diabetic Wounds
por: Tang, Yunan, et al.
Publicado: (2013) -
The Effects of Proresolution of Ellagic Acid in an Experimental Model of Allergic Airway Inflammation
por: de Freitas Alves, Claudiney, et al.
Publicado: (2013) -
In vitro and in vivo assessment of the proresolutive and antiresorptive actions of resolvin D1: relevance to arthritis
por: Benabdoun, Houda Abir, et al.
Publicado: (2019) -
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
por: García, Ricardo A., et al.
Publicado: (2021) -
Measles IgG Antibody Index Correlates with T2 Lesion Load on MRI in Patients with Early Multiple Sclerosis
por: Rosche, Berit, et al.
Publicado: (2012)